CYDY has posted an update to their FAQ page. I did

CYDY has posted an update to their FAQ page. I did a quick check vs. one from a few months ago, and I think the only update is what we already know about arbitration. Here is that update:

Quote:

---

What is the current status of the Amarex litigation effort?

In July 2023, the Company took the next step towards holding Amarex, its former clinical research organization (CRO), accountable for its numerous failures in relation to clinical trial management and regulatory services it was supposed to have provided to CytoDyn. The Company is seeking damages in excess of $100 million from Amarex in this action. We have fully funded the Company’s counsel, Sidley Austin LLP, for this litigation effort in advance, which allows them to take all steps necessary to maximize the Company’s recovery from Amarex. The final arbitration hearing was recently rescheduled, and is now ordered to commence on November 11, 2024. The parties are in the discovery phase of the litigation, and will also be participating in structured settlement discussions over the next several months.

---

https://www.cytodyn.com/investors/investor-faqs